Human immunodeficiency virus type 1 Tat increases the expression of cleavage and polyadenylation specificity factor 73-kilodalton subunit modulating cellular and viral expression

Journal of Virology

Volumn 78, Issue 13, 2004, Pages 6846-6854

  Calzado, Marco A ^a   Sancho, Rocío ^a   Muñoz, Eduardo ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; DOXYCYCLINE; MESSENGER RNA; MESSENGER RNA PRECURSOR; PROTEIN CPSF3; PROTEIN MDM2; PROTEIN SUBUNIT; REGULATOR PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL INTERACTION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; GENE; GENE OVEREXPRESSION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MDM2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEIOTROPY; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA PROCESSING; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS REPLICATION;

CELL LINE; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HELA CELLS; HIV-1; HUMANS; PROTEINS; RNA, MESSENGER; UP-REGULATION; VIRAL PROTEINS;

EID: 2942639515     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.13.6846-6854.2004     Document Type: Article

References (64)

1. Barak, Y., E. Gottlieb, T. Juven-Gershon, and M. Oren. 1994. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8:1739-1749.
2. Benkirane, M., R. F. Chun, H. Xiao, V. V. Ogryzko, B. H. Howard, Y. Nakatani, and K. T. Jeang. 1998. Activation of integrated provirus requires histone acetyltransferase: p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 273:24898-24905.
3. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7056-7065.
4. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66:7159-7167.
5. Caldwell, R. L., B. S. Egan, and V. L. Shepherd. 2000. HIV-1 Tat represses transcription from the mannose receptor promoter. J. Immunol. 165:7035-7041.
6. Calnan, B. J., B. Tidor, S. Biancalana, D. Hudson, and A. D. Frankel. 1991. Arginine-mediated RNA recognition: the arginine fork. Science 252:1167-1171.
7. Colgan, D. F., and J. L. Manley. 1997. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2755-2766.
8. Custodio, N., M. Carmo-Fonseca, F. Geraghty, H. S. Pereira, F. Grosveld, and M. Antoniou. 1999. Inefficient processing impairs release of RNA from the site of transcription. EMBO J. 18:2855-2866.
9. Chanfreau, G., S. M. Noble, and C. Guthrie. 1996. Essential yeast protein with unexpected similarity to subunits of mammalian cleavage and polyadenylation specificity factor (CPSF). Science 274:1511-1514.
10. Chang, H. K., R. C. Gallo, and B. Ensoli. 1995. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J. Biomed. Sci. 2:189-202.
11. Chirillo, P., M. Falco, P. L. Puri, M. Artini, C. Balsano, M. Levrero, and G. Natoli. 1996. Hepatitis B virus pX activates NF-KB-dependent transcription through a Raf-independent pathway. J. Virol. 70:641-646.
12. Dantonel, J. C., K. G. Murthy, J. L. Manley, and L. Tora. 1997. Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA. Nature 389:399-402.
13. de la Fuente, C., F. Santiago, L. Deng, C. Eadie, I. Zilberman, K. Kehn, A. Maddukuri, S. Baylor, K. Wu, C. G. Lee, A. Pumfery, and F. Kashanchi. 2002. Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals. BMC Biochem. 3:14.
14. DeZazzo, J. D., J. M. Scott, and M. J. Imperiale. 1992. Relative roles of signals upstream of AAUAAA and promoter proximity in regulation of human immunodeficiency virus type 1 mRNA 3′ end formation. Mol. Cell. Biol. 12:5555-5562.
15. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, and M. A. Skinner. 1990. HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:4145-4153.
16. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
17. Emerman, M., and M. H. Malim. 1998. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280:1880-1884.
18. Ford, L. P., P. S. Bagga, and J. Wilusz. 1997. The poly(A) tail inhibits the assembly of a 3′-to-5′ exonuclease in an in vitro RNA stability system. Mol. Cell. Biol. 17:398-406.
19. Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20:6958-6969.
20. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363. (Erratum, 6:606.)
21. Gaynor, R. B. 1995. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 193:51-77.
22. Gibellini, D., M. C. Re, M. La Placa, and G. Zauli. 2002. Differentially expressed genes in HIV-1 tat-expressing CD4(+) T-cell line. Virus Res. 90:337-345.
23. Gonzalez, E., C. Punzon, M. Gonzalez, and M. Fresno. 2001. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. J. Immunol. 166:4560-4569.
24. Gonzalez-Dunia, D., S. Chirinian-Syan, M. Brahic, and S. Ozden. 1992. Functional analysis of two long terminal repeats from the HTLV-I retrovirus. Gene 116:151-158.
25. Hilleren, P., and R. Parker. 2001. Defects in the mRNA export factors Rat7p, Gle1p, Mex67p, and Rat8p cause hyperadenylation during 3′-end formation of nascent transcripts. RNA 7:753-764.
26. Hirose, Y., and J. L. Manley. 2000. RNA polymerase II and the integration of nuclear events. Genes Dev. 14:1415-1429.
27. Hirose, Y., and J. L. Manley. 1998. RNA polymerase II is an essential mRNA polyadenylation factor. Nature 395:93-96.
28. Huang, L., I. Bosch, W. Hofmann, J. Sodroski, and A. B. Pardee. 1998. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J. Virol. 72:8952-8960.
29. Huang, Y., and G. C. Carmichael. 1996. Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol. Cell. Biol. 16:1534-1542.
30. Israel, N., M. A. Gougerot-Pocidalo, F. Aillet, and J. L. Virelizier. 1992. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 149:3386-3393.
31. Izmailova, E., F. M. Bertley, Q. Huang, N. Makori, C. J. Miller, R. A. Young, and A. Aldovini. 2003. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat. Med. 9:191-197.
32. Jenny, A., L. Minvielle-Sebastia, P. J. Preker, and W. Keller. 1996. Sequence similarity between the 73-kilodalton protein of mammalian CPSF and a subunit of yeast polyadenylation factor I. Science 274:1514-1517.
33. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
34. Kamp, W., M. B. Berk, C. J. Visser, and H. S. Nottet. 2000. Mechanisms of HIV-1 to escape from the host immune surveillance. Eur. J. Clin. Investig. 30:740-746.
35. Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Antitermination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330:489-493.
36. Karn, J. 1999. Tackling Tat. J. Mol. Biol. 293:235-254.
37. Kato, H., H. Sumimoto, P. Pognonec, C. H. Chen, C. A. Rosen, and R. G. Roeder. 1992. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes Dev. 6:655-666.
38. Keller, W. 1995. No end yet to messenger RNA 3′ processing! Cell 81:829-832.
39. Keller, W., and L. Minvielle-Sebastia. 1997. A comparison of mammalian and yeast pre-mRNA 3′-end processing. Curr. Opin. Cell Biol. 9:329-336.
40. Laspia, M. F., P. Wendel, and M. B. Mathews. 1993. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J. Mol. Biol. 232:732-746.
41. Li, C. J., C. Wang, D. J. Friedman, and A. B. Pardee. 1995. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:5461-5464.
42. Longo, F., M. A. Marchetti, L. Castagnoli, P. A. Battaglia, and F. Gigliani. 1995. A novel approach to protein-protein interaction: complex formation between the p53 tumor suppressor and the HIV Tat proteins. Biochem. Biophys. Res. Commun. 206:326-334.
43. Macho, A., M. A. Calzado, L. Jimenez-Reina, E. Ceballos, J. Leon, and E. Munoz. 1999. Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms. Oncogene 18:7543-7551.
44. McCracken, S., M. Lambermon, and B. J. Blencowe. 2002. SRm160 splicing coactivator promotes transcript 3′-end cleavage. Mol. Cell. Biol. 22:148-160.
45. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
46. Mouland, A. J., M. Coady, X. J. Yao, and E. A. Cohen. 2002. Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression. Virology 292:321-330.
47. Murthy, K. G., and J. L. Manley. 1995. The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3′-end formation. Genes Dev. 9:2672-2683.
48. Ott, M., J. L. Lovett, L. Mueller, and E. Verdin. 1998. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J. Immunol. 160:2872-2880.
49. Preiss, T., and M. W. Hentze. 1998. Dual function of the messenger RNA cap structure in poly(A)-tail-promoted translation in yeast. Nature 392:516-520.
50. Preker, P. J., M. Ohnacker, L. Minvielle-Sebastia, and W. Keller. 1997. A multisubunit 3′ end processing factor from yeast containing poly(A) polymerase and homologues of the subunits of mammalian cleavage and polyadenylation specificity factor. EMBO J. 16:4727-4737.
51. Proudfoot, N. J., A. Furger, and M. J. Dye. 2002. Integrating mRNA processing with transcription. Cell 108:501-512.
52. Roy, S., M. G. Katze, N. T. Parkin, I. Edery, A. G. Hovanessian, and N. Sonenberg. 1990. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216-1219.
53. Sachs, A. B., P. Sarnow, and M. W. Hentze. 1997. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89:831-838.
54. Scott, J. M., and M. J. lmperiale. 1997. Promoter-proximal poly(A) sites are processed efficiently, but the RNA products are unstable in the nucleus. Mol. Cell. Biol. 17:2127-2135.
55. Secchiero, P., D. Zella, S. Capitani, R. C. Gallo, and G. Zauli. 1999. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J. Immunol. 162:2427-2431.
56. Verhoef, K., M. Bauer, A. Meyerhans, and B. Berkhout. 1998. On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. AIDS Res. Hum. Retroviruses 14:1553-1559.
57. Wahle, E. 1995. Poly(A) tail length control is caused by termination of processive synthesis. J. Biol. Chem. 270:2800-2808.
58. Wahle, E., and U. Kuhn. 1997. The mechanism of 3′ cleavage and polyadenylation of eukaryotic pre-mRNA. Prog. Nucleic Acid Res. Mol. Biol. 57:41-71.
59. Weeks, K. M., C. Ampe, S. C. Schultz, T. A. Steitz, and D. M. Crothers. 1990. Fragments of the HIV-1 Tat protein specifically bind TAR RNA. Science 249:1281-1285.
60. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
61. Wickens, M., P. Anderson, and R. J. Jackson. 1997. Life and death in the cytoplasm: messages from the 3′ end. Curr. Opin. Genet. Dev. 7:220-232.
62. Willard-Gallo, K. E., M. Furtado, A. Burny, and S. M. Wolinsky. 2001. Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes. Eur. J. Immunol. 31:969-979.
63. Zhao, J., L. Hyman, and C. Moore. 1999. Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev. 63:405-445.
64. Zhou, M., S. Nekhai, D. C. Bharucha, A. Kumar, H. Ge, D. H. Price, J. M. Egly, and J. N. Brady. 2001. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. J. Biol. Chem. 276:44633-44640.